Moderna President Stephen Hoge sold 39,145 shares of Moderna, Inc. ($MRNA) on October 15, 2026. The open-market transaction was priced at $220.72 per share, for a total of $8,640,084.40. A Form 4 filed October 16, 2026, one day after the trade, disclosed the sale. Afterward, Hoge reported holding 1,636,565 shares. Moderna is classified in the biotechnology sector.
The October 15 sale followed two open-market sales by Hoge on October 14. He sold 38,774 shares at $213.47 per share for $8,277,085.78 and 450 shares at $214.15 per share for $96,367.50. Together, the three transactions on October 14 and October 15 totaled $17,013,537.68. Both October 14 sales were disclosed in filings dated October 16, 2026, two days after those trades.
Hoge reported other open-market Moderna sales earlier in 2026. On July 15, he sold 53,336 shares at $67.60 per share for $3,605,513.60. On May 15, he sold 53,336 shares at $48.40 per share for $2,581,462.40. On February 23, he sold 160,009 shares at $48.84 per share for $7,814,839.56. Across his six reported 2026 sales through October 15, Hoge sold 345,050 shares for $31,015,353.24.
Other Moderna insiders reported open-market sales over the same stretch. Chief Legal Officer Shannon Thyme Klinger sold 3,471 shares on September 1 at $139.95 per share for $485,766.45, and 13,885 shares on March 2 at $52.29 per share for $726,046.65. Director Noubar Afeyan sold 9,263 shares on May 21 at $46.84 per share for $433,878.92, and 23,853 shares on December 11, 2025, at $29.485 per share for $703,305.71. Director Abbas Hussain sold 5,682 shares on May 1 at $46.63 per share for $264,951.66, and 504 shares on December 9, 2025, at $27.60 per share for $13,910.40.
The records from December 2025 through October 2026 listed 12 open-market sale transactions for Moderna insiders. They covered 401,708 shares and $33,643,213.03 in reported proceeds. Hoge's six transactions represented 345,050 shares and $31,015,353.24 of that total. The six sales by other Moderna insiders accounted for the remaining $2,627,859.79. Each of the 12 transactions was listed as a sale.
The October 15 per-share price of $220.72 was higher than the per-share prices disclosed for Hoge's July 15 sale at $67.60 and May 15 sale at $48.40. Moderna's most recent available closing price before the transaction date was $203.21 on October 5, 2026. Hoge's reported position after the October 15 sale stood at 1,636,565 shares. The Form 4 identified the transaction as an open-market sale.